R&D of New and Existing Products
First written in FY2016. 20 of 25 entries say "Restated". Latest entry: FY2026.
34 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Specifically, research and development of new products, including various inorganic composite oxides for encapsulants, toner, heat shielding and water treatment, as well as titanium dioxide for cosmetics and dispersions, is producing steady results. Total research and development expenses during the fiscal year were ¥239 million.」
Inorganic composite oxides for water treatment were added to the subjects of new product research, and research and development expenses were ¥239 million. - FY2026-H1RestatedAnnual report
「R&D expenses for the interim consolidated accounting period were ¥120 million. There were no material changes in the status of the group's research and development activities during the interim consolidated accounting period.」
The company stated that there were no material changes in research and development activities for new and existing products and recorded research and development expenses of ¥120 million. - FY2025-H1RestatedAnnual report
「R&D expenses for the interim consolidated accounting period amounted to ¥119 million. There were no material changes in the status of the Group's R&D activities during the interim consolidated accounting period.」
The company stated that there were no material changes in research and development activities for new and existing products. - FY2024-Q3RestatedAnnual report
「R&D expenses for the nine-month cumulative period of the third quarter of the current consolidated fiscal year amounted to ¥182 million. There were no material changes in the status of the Group's R&D activities during the nine-month cumulative period of the third quarter of the current consolidated fiscal year.」
The disclosure continues to state that there have been no material changes in research and development activities for new and existing products, and research and development expenses of ¥182 million were recorded. - FY2024-Q2RestatedAnnual report
「R&D expenses for the six-month cumulative period of the second quarter of the current consolidated fiscal year amounted to ¥121 million. There were no material changes in the status of the Group's R&D activities during the six-month cumulative period of the second quarter of the current consolidated fiscal year.」
The disclosure continues to state that there have been no material changes in research and development activities for new and existing products, and research and development expenses of ¥121 million were recorded. - FY2024-Q1RestatedAnnual report
「R&D expenses for the three-month cumulative period of the first quarter of the current consolidated fiscal year amounted to ¥58 million. There were no material changes in the status of the Group's R&D activities during the three-month cumulative period of the first quarter of the current consolidated fiscal year.」
The company stated that there were no material changes in research and development activities for new and existing products and recorded research and development expenses of ¥58 million. - FY2023AdvancedAnnual report
「Specifically, research and development of new products, including ultrafine titanium dioxide, conductive inorganic composite oxides, inorganic composite oxides for encapsulants, toner and heat shielding, cosmetic powders and dispersions, is producing steady results. Total research and development expenses during the fiscal year were ¥260 million.」
Inorganic composite oxides for encapsulants, toner and heat shielding were explicitly identified as research and development subjects, and research and development expenses of ¥260 million disclosed the specific scale of the activities. - FY2023-Q2RestatedAnnual report
「R&D expenses for the six-month cumulative period of the second quarter of the current consolidated fiscal year amounted to ¥129 million. There were no material changes in the status of the Group's R&D activities during the six-month cumulative period of the second quarter of the current consolidated fiscal year.」
The disclosure continues to state that there have been no material changes in research and development activities for new and existing products, and research and development expenses of ¥129 million were recorded. - FY2023-Q1RestatedAnnual report
「R&D expenses for the cumulative first quarter of the consolidated fiscal year were ¥63 million. There were no material changes in the status of the group's research and development activities during the cumulative first quarter of the consolidated fiscal year.」
The company continues to state that there have been no material changes in its research and development activities for new and existing products. - FY2022AdvancedAnnual report
「During the fiscal year, based on our management policy, we worked on developing new products linked to business structural transformation and long-term growth, while also actively pursuing research into improvements and applications for existing products. Specifically, research and development of new products, including ultrafine titanium dioxide, conductive inorganic oxides, inorganic composite oxides for encapsulants and toner, cosmetic powders and dispersions, is producing steady results.」
Inorganic composite oxides for encapsulants and toner were explicitly included among the subjects of new product research, and research and development expenses were ¥295 million. - FY2022-Q3RestatedAnnual report
「R&D expenses for the cumulative third quarter of the consolidated fiscal year were ¥218 million. There were no material changes in the status of the group's research and development activities during the cumulative third quarter of the consolidated fiscal year.」
The company continues to state that there have been no material changes in its research and development activities for new and existing products. - FY2022-Q2RestatedAnnual report
「R&D expenses for the cumulative second quarter of the consolidated fiscal year were ¥143 million. There were no material changes in the status of the group's research and development activities during the cumulative second quarter of the consolidated fiscal year.」
The company continues to state that there have been no material changes in its research and development activities for new and existing products. - FY2021-Q3RestatedAnnual report
「R&D expenses for the cumulative third quarter of the consolidated fiscal year were ¥235 million. There were no material changes in the status of the group's research and development activities during the cumulative third quarter of the consolidated fiscal year.」
The disclosure continues to state that there have been no material changes in research and development activities for new and existing products. Research and development expenses were ¥235 million. - FY2021-Q1RestatedAnnual report
「R&D expenses for the cumulative first quarter of the consolidated fiscal year were ¥76 million. There were no material changes in the status of the group's research and development activities during the cumulative first quarter of the consolidated fiscal year.」
The disclosure continues to state that there have been no material changes in research and development activities for new and existing products. Research and development expenses were ¥76 million. - FY2020RestatedAnnual report
「Specifically, research and development of new products, including ultrafine titanium dioxide, conductive inorganic oxides, inorganic composite oxides, cosmetic powders and dispersions, is producing steady results. For existing products, we are conducting research into improvements and applications for iron oxide pigments, iron oxide for toner and other products, and are advancing development aligned with the product life cycle, with decisions to adopt the products being made successively.」
Research and development of new products and research into improvements and applications for existing products continued, producing results including successive adoption decisions. Research and development expenses were ¥314 million. - FY2020-Q3RestatedAnnual report
「R&D expenses for the cumulative third quarter of the consolidated fiscal year were ¥239 million. There were no material changes in the status of the group's research and development activities during the cumulative third quarter of the consolidated fiscal year.」
The company continues to state that there have been no material changes in its research and development activities for new and existing products. R&D expenses were ¥239 million. - FY2020-Q2RestatedAnnual report
「R&D expenses for the cumulative second quarter of the consolidated fiscal year were ¥163 million. There were no material changes in the status of the group's research and development activities during the cumulative second quarter of the consolidated fiscal year.」
The company continues to state that there have been no material changes in its research and development activities for new and existing products. R&D expenses were ¥163 million. - FY2020-Q1RestatedAnnual report
「R&D expenses for the cumulative first quarter were ¥79 million. There were no material changes in the status of the company's research and development activities during the cumulative first quarter.」
The company continues to state that there have been no material changes in its research and development activities for new and existing products. R&D expenses were ¥79 million. - FY2019RestatedAnnual report
「Specifically, for new products, the company is pursuing research and development of ultrafine titanium dioxide, conductive inorganic oxides, inorganic composite oxides, battery materials, cosmetic powders and dispersions, among others, and is achieving steady results. For existing products, it is conducting research into improvements and applications for pigment-grade iron oxide and toner-grade iron oxide, among others, with successive adoption decisions being made, enabling the company to respond smoothly to product life cycles.」
The company continues to develop new products in parallel with improvement and application research for existing products. - FY2019-Q3RestatedAnnual report
「There were no material changes in the status of the Company’s R&D activities during the cumulative third-quarter period.」
The company continues to state that there have been no material changes in its research and development activities for new and existing products. - FY2019-Q2RestatedAnnual report
「R&D expenses for the cumulative second quarter were ¥137 million. There were no material changes in the status of the company's research and development activities during the cumulative second quarter.」
The company continues to state that there have been no material changes in its research and development activities for new and existing products. - FY2019-Q1RestatedAnnual report
「There were no material changes in the status of the Company’s R&D activities during the cumulative first-quarter period.」
The company stated that there were no material changes in its research and development activities for new and existing products. - FY2018RestatedAnnual report
「Specifically, for new products, the company is pursuing research and development of ultrafine titanium dioxide, conductive inorganic oxides, inorganic composite oxides, battery materials, cosmetic powders and dispersions, among others, and is achieving steady results. For existing products, it is conducting research into improvements and applications for pigment-grade iron oxide and toner-grade iron oxide, among others, with successive adoption decisions being made, enabling the company to respond smoothly to product life cycles.」
The company continues to describe its R&D targets and the adoption record for existing products. - FY2017AdvancedAnnual report
「Specifically, for new products, the company is pursuing research and development of ultrafine titanium dioxide, conductive inorganic oxides, inorganic oxide composite materials, battery materials, cosmetic powders and dispersions, among others, and is achieving steady results. For existing products, it is conducting research into improvements and applications for pigment-grade iron oxide and toner-grade iron oxide, among others, with successive adoption decisions being made, enabling the company to respond smoothly to product life cycles.」
For the full fiscal year, the company disclosed the specific targets and results, including adoption decisions, of its research and development of new products and improvement and application research for existing products. - FY2016First statedAnnual report
「Specifically, for new products, the company is pursuing research and development of ultrafine titanium dioxide, conductive inorganic oxides, inorganic oxide composite materials, battery materials, cosmetic powders and dispersions, among others, and is achieving steady results. For existing products, it is conducting research into improvements and applications for pigment-grade iron oxide and toner-grade iron oxide, among others, with successive adoption decisions being made, enabling the company to respond smoothly to product life cycles.」
The company is advancing the development of new products alongside improvement and application research for existing products, and recorded R&D expenses of ¥235 million.